Property:Financial Disclosures

From EyeWiki

This property has type text.

Showing 20 pages using this property.
D
"None"  +
V
"None"  +
J
V
S
1. Consultant, Alcon  +
M
AMO-Abbott, Allergan, Bausch & Lomb, Inspire, Vistakon, Santen, Pfizer, FOCUS Laboratories, Aton Pharma, Ocularis Pharma, Ace Vision Group, VISION3  +
B
AbbVie (Consultant, Speaker) Alcon (Consultant, Speaker) CorneaGen( Consultant) Dompe (Consultant) Glaukos (Consultant)  +
J
Acufocus, Bausch + Lomb, Johnson & Johnson Vision, Shire, TearLab  +
D
Ad hoc consultant for Alcon, Alimera, Bausch & Lomb, Genentech, Glaukos, and Thrombogenics  +
Advisor/Consultant: Astellas, Apellis, Alimera Sciences, EyePoint Pharmaceuticals, Genentech, Regeneron, ONL Therapeutics, Verana Health, Speaker: Astellas  +
N
Advisory Board, Alimera Sciences Advisory Board, Allergan Advisory Board, Optos  +
A
Advisory Board, Immunocore  +
Aerie Pharmaceuticals (S), New World Medical, Inc (C)  +
Alcon (Consultant), Allergan (Consultant, Investigator), Aerie (Consultant, Investigator), IQVIA (Data Safety Monitor)  +
S
Alcon (speaker)  +
P
Alcon (speaker) Inspire (speaker) Pfizer (consultant) Johnson & Johnson (advisory board) Bausch & Lomb (advisory board) Paragon (speaker) Vistakon (speaker)  +
S
Alcon - patent royalties. Genentech - consultant. Allergan - consultant.  +
K
Alcon Laboratories Johnson & Johnson Vision  +
P
Alcon Laboratories - Research Support  +
R
Alcon Laboratories, Inc. (L) Allergan (S) Carl Zeiss Meditec (S) Novartis Pharmaceuticals Corporation (C,L)  +
The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.